Behavior Science Flashcards

0
Q

Case control study

A

Observational, retrospective
Compare a group w disease to a group wo disease n look for exposure or risk factors
What happened
Measures odds ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Cross sectional study

A

Data from a group at a particular point in time
What is happening
Measures Disease prevalence
Establish association not causality between risk factors and disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cohort study

A

Observational, prospective or retrospective
Compares group w exposure to group wo n looks to see if exposure inc likelihood of disease
Who will develop or who did given exposure
Measures relative risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Four phases of clinical drug trial

A

Phase 1: small number of healthy, is drug safe, assess toxicity pharmakinetics

Phase 2: small number of patients, does it work, assess treatment efficacy and optimal dosage and side effects

Phase 3: large group randomized w control (placebo or best available), is it good or better, compare w existing treatment

Phase 4: post marketing surveillance, can it stay, long term adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sensitivity

A

Proportion of all people with disease who test positive, or the probability that a test detects disease when disease is present

Value approaching 100% is desirable for ruling out and indicate low false negative rate

Best for screening test

=TP / (TP + FN) = 1 - false negative

SN-N-OUT highly sensitive test when negative rules out disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Specificity

A

Proportion of all people without disease who test negative, or the probability that a test indicates non-disease when disease is absent

Value approaching 100% is desirable for ruling in disease and indicates a low-false positive rate

Best for confimrational diagnostic after positive screening

=TN / (TN+FP) = 1 - false positive
SP-P-IN highly specific test, when positive, rules in diseae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Negative predictive value

A

Proportion of negative test results that are true negative

Probability that person actually is disease free given negative test result

=TN / (TN+FN)

High prevalence or pretest probability = low NPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Positive predictive value

A

Proportion of positive test results that are true positive

Probability that person actually has the disease given positive result

=TP/ (TP+FP)

High prevalence or pretest probability = high PPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Incidence rate

A

Number of new cases in a specified time period / population at risk during same time period

Looks at new cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prevalence

A

Number of existing cases / population at risk

Looks at all current cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Odds ratio

A

Uses in case control studies

Odds that the group with the disease was exposed over the odds that the group w/o the disease was exposed

(a/c)/(b/d) = ad/bc where a and c are small (low prevalence of disease)
A is those with disease and exposed
C is those with disease and unexposed
B is those without disease and exposed
D is those without disease and unexposed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Relative risk

A

Used in cohort studies

Risk of developing disease in exposed group over risk of developing disease in unexposed group

(a/(a+b))/(c/(c+d))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Relative risk reduction

A

The proportion of risk reduction attributable to intervention as compared to control, RRR= 1-RR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Attributable risk

A

The difference in risk between exposed and unexposed that is attributable to exposure

AR = a/a+b - c/c+d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Absolute risk reduction

A

The difference in risk attributable to intervention as compared to a control (raw number percentage)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Numbers need to treat

A

Number of patients who need to treated for 1 to benefit

=1/ARR

16
Q

Number needed to harm

A

Number of patients who need to be exposed to a risk factor to be harmed

=1/AR

17
Q

Selection bias

A

Non random assignment to participate in a study group

Study only look at inpatients, studying disease w early mortality but high loss to f/u, studying health workers and volunteers

Can be avoided w randomization

18
Q

Recall bias

A

Awareness of disorder alters recall by subjects, common in retrospective studies

Patients w disease recall exposure after learning similar cases

Avoided by decreasing time from exposure to follow u

19
Q

Measurement bias

A

Information is gathered in a way that distorts it

Hawthorne effect: groups who know they are being studied behave differently than if they didn’t know

Avoided with placebo control or blinding studies

20
Q

Procedure bias

A

Subjects in diff groups are not treated the same

Use sham methods to equalize study groups

21
Q

Observer bias

A

Researcher’s belief in efficacy of treatment changes outcome, self fulfilling prophecy

Avoid w double blind studies

22
Q

Confounding bias

A

When a factor is related to both exposure and outcome but not the causal pathway

Ex: pulmonary disease, coal mines, smoking

Corrected w crossover studies or matching pts w similar characteristics in study groups

23
Q

Lead time bias

A

Early detection is confused w increased survival, often seen w screening techs

Corrected w back end survival measurement, ex: adjust survival according to severity at time of diagnosis

24
Q

Null hypotheses

A

Hypothesis of no difference (no association between risk factor and disease)

25
Q

Alternative hypotheses

A

Some difference (association between disease and risk factor)

26
Q

Type1 error

A

Stating there is an effect or difference when there is none

27
Q

Type2 error

A

Stating there is no difference when there is none

28
Q

Meta analysis

A

Pools data and integrates results from several similar studies to reach overall conclusion

Limited by quality of individual studies or boas in study selection

29
Q

T -test

A

Check differences between means of two groups

30
Q

ANOVA test

A

Check differences between means of 3 or more groups

31
Q

Chi square test

A

Check differences between 2 or more percentages or proportions of categorical outcomes rather than means

32
Q

Stages of disease prevention

A

Primary: prevent disease occurrence, vaccinations

Secondary: screening, Pap smears

Tertiary: treatment, surgery or chemo

Quanternary: prevent unnecessary treatment

33
Q

APGAR score

A

Assess newborns at 1 min and 5 min on 10 pt scale

Based on appearance, pulse, grimace, activity, respiration

> 7 good, < 4 resuscitate